关注
Magnus Åstrand
Magnus Åstrand
Senior Pharmacometrician, AstraZeneca R&D
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad, RA Irizarry, M Åstrand, TP Speed
Bioinformatics 19 (2), 185-193, 2003
99962003
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
AL Krarup, L Ny, M Åstrand, A Bajor, F Hvid‐Jensen, MB Hansen, ...
Alimentary pharmacology & therapeutics 33 (10), 1113-1122, 2011
1492011
Contrast normalization of oligonucleotide arrays
M Åstrand
Journal of Computational Biology 10 (1), 95-102, 2003
1072003
Effect of tenapanor on serum phosphate in patients receiving hemodialysis
GA Block, DP Rosenbaum, M Leonsson-Zachrisson, M Åstrand, ...
Journal of the American Society of Nephrology 28 (6), 1933-1942, 2017
1062017
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled …
HJL Heerspink, A Kiyosue, DC Wheeler, M Lin, E Wijkmark, G Carlson, ...
The Lancet 402 (10416), 2004-2017, 2023
542023
The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD 2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers
WO Rohof, A Lei, DP Hirsch, L Ny, M Astrand, MB Hansen, ...
Alimentary pharmacology & therapeutics 35 (10), 1231-1242, 2012
452012
Endocrine and behavioral traits in low-avoidance performing Sprague–Dawley rats
K Uvnäs-Moberg, E Björkstrand, P Salmi, C Johansson, M Åstrand, ...
Regulatory peptides 80 (1-2), 75-82, 1999
251999
Activity of neutrophil elastase reflects the progression of acute pancreatitis
S Novovic, AM Andersen, M Nord, M Åstrand, T Ottosson, LN Jørgensen, ...
Scandinavian journal of clinical and laboratory investigation 73 (6), 485-493, 2013
222013
Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients
M Åstrand, C Amilon, D Röshammar, A Himmelmann, DJ Angiolillo, ...
British Journal of Clinical Pharmacology 85 (2), 413-421, 2019
172019
A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?
PO Katz, DA Johnson, D Levine, K Röhss, O Junghard, M Åstrand, ...
Alimentary pharmacology & therapeutics 32 (3), 443-447, 2010
172010
Empirical Bayes models for multiple probe type microarrays at the probe level
M Åstrand, P Mostad, M Rudemo
BMC bioinformatics 9, 1-11, 2008
172008
Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH> 4
DA Johnson, PO Katz, D Levine, K Röhss, M Åstrand, O Junghard, ...
Journal of clinical gastroenterology 44 (7), 475-478, 2010
162010
Population pharmacokinetics/pharmacodynamics of ticagrelor in children with sickle cell disease
C Amilon, M Niazi, A Berggren, M Åstrand, B Hamrén
Clinical Pharmacokinetics 58, 1295-1307, 2019
142019
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
MM Heeney, MR Abboud, J Githanga, BPD Inusa, J Kanter, AD Michelson, ...
Blood, The Journal of the American Society of Hematology 140 (13), 1470-1481, 2022
132022
Pharmacokinetics of roxadustat: a population analysis of 2855 dialysis-and non-dialysis-dependent patients with chronic kidney disease
D Rekić, V Kerbusch-Herben, M Någård, J Chou, J Huang, C Bradley, ...
Clinical Pharmacokinetics 60, 759-773, 2021
112021
Improved covariance matrix estimators for weighted analysis of microarray data
M Åstrand, P Mostad, M Rudemo
Journal of Computational Biology 14 (10), 1353-1367, 2007
112007
Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus
J Parkinson, W Tang, M Åstrand, J Melin, E Ekholm, B Hamrén, ...
Diabetes, Obesity and Metabolism 21 (6), 1381-1387, 2019
72019
Effect of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower esophageal sphincter relaxations and reflux episodes in healthy males
WO Rohof, A Lei, D Hirsch, M Åstrand, L Ny, MB Hansen, ...
Gastroenterology 5 (140), S-66, 2011
62011
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged< 24 months
BP Duniva Inusa, A Inati, P Maes, J Githanga, B Ogutu, MR Abboud, ...
Pediatric Blood & Cancer 68 (5), e28977, 2021
42021
Normalization and differential gene expression analysis of microarray data
M Åstrand
PQDT-Global, 2008
42008
系统目前无法执行此操作,请稍后再试。
文章 1–20